101 related articles for article (PubMed ID: 22901716)
1. Induction of apolipoprotein A-I gene expression by glucagon-like peptide-1 and exendin-4 in hepatocytes but not intestinal cells.
Chehade JM; Alcalde R; Naem E; Mooradian AD; Wong NC; Haas MJ
Metabolism; 2013 Feb; 62(2):265-74. PubMed ID: 22901716
[TBL] [Abstract][Full Text] [Related]
2. Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes.
Lyu J; Imachi H; Fukunaga K; Sato S; Kobayashi T; Dong T; Saheki T; Matsumoto M; Iwama H; Zhang H; Murao K
Mol Metab; 2020 Apr; 34():16-26. PubMed ID: 32180556
[TBL] [Abstract][Full Text] [Related]
3. Induction of apolipoprotein A-I gene expression by black seed (Nigella sativa) extracts.
Haas MJ; Onstead-Haas LM; Naem E; Wong NC; Mooradian AD
Pharm Biol; 2014 Sep; 52(9):1119-27. PubMed ID: 24635344
[TBL] [Abstract][Full Text] [Related]
4. Nicotinic acid induces apolipoprotein A-I gene expression in HepG2 and Caco-2 cell lines.
Haas MJ; Alamir AR; Sultan S; Chehade JM; Wong NC; Mooradian AD
Metabolism; 2011 Dec; 60(12):1790-6. PubMed ID: 21664629
[TBL] [Abstract][Full Text] [Related]
5. Exendin-4 Ameliorates Lipotoxicity-induced Glomerular Endothelial Cell Injury by Improving ABC Transporter A1-mediated Cholesterol Efflux in Diabetic apoE Knockout Mice.
Yin QH; Zhang R; Li L; Wang YT; Liu JP; Zhang J; Bai L; Cheng JQ; Fu P; Liu F
J Biol Chem; 2016 Dec; 291(51):26487-26501. PubMed ID: 27784780
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of apolipoprotein A-I gene expression by obesity-associated endocannabinoids.
Haas MJ; Mazza AD; Wong NC; Mooradian AD
Obesity (Silver Spring); 2012 Apr; 20(4):721-9. PubMed ID: 22016100
[TBL] [Abstract][Full Text] [Related]
7. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
Ligumsky H; Wolf I; Israeli S; Haimsohn M; Ferber S; Karasik A; Kaufman B; Rubinek T
Breast Cancer Res Treat; 2012 Apr; 132(2):449-61. PubMed ID: 21638053
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-Like Peptide-1 Modulates Cholesterol Homeostasis by Suppressing the miR-19b-Induced Downregulation of ABCA1.
Yao Y; Li Q; Wang W; Zhang J; Gao P; Xu Y
Cell Physiol Biochem; 2018; 50(2):679-693. PubMed ID: 30308521
[TBL] [Abstract][Full Text] [Related]
9. Induction of hepatic apolipoprotein A-I gene expression by the isoflavones quercetin and isoquercetrin.
Haas MJ; Onstead-Haas LM; Szafran-Swietlik A; Kojanian H; Davis T; Armstrong P; Wong NC; Mooradian AD
Life Sci; 2014 Aug; 110(1):8-14. PubMed ID: 24963805
[TBL] [Abstract][Full Text] [Related]
10. Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes.
Kim JY; Lee SK; Jo KJ; Song DY; Lim DM; Park KY; Bonewald LF; Kim BJ
Life Sci; 2013 Mar; 92(10):533-40. PubMed ID: 23357248
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 1 (GLP-1)-based therapy upregulates LXR-ABCA1/ABCG1 cascade in adipocytes.
Mostafa AM; Hamdy NM; El-Mesallamy HO; Abdel-Rahman SZ
Biochem Biophys Res Commun; 2015 Dec; 468(4):900-5. PubMed ID: 26603933
[TBL] [Abstract][Full Text] [Related]
12. Central Nervous System Regulation of Intestinal Lipoprotein Metabolism by Glucagon-Like Peptide-1 via a Brain-Gut Axis.
Farr S; Baker C; Naples M; Taher J; Iqbal J; Hussain M; Adeli K
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1092-100. PubMed ID: 25675997
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
[TBL] [Abstract][Full Text] [Related]
14. HNF4α increases liver-specific human ATP-binding cassette transporter A1 expression and cholesterol efflux to apolipoprotein A-I in response to cholesterol depletion.
Ohoka N; Okuhira K; Cui H; Wu W; Sato R; Naito M; Nishimaki-Mogami T
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1005-14. PubMed ID: 22282358
[TBL] [Abstract][Full Text] [Related]
15. Divergent effects of GLP-1 analogs exendin-4 and exendin-9 on the expression of myosin heavy chain isoforms in C2C12 myotubes.
Wang L; Guo F; Wei S; Zhao R
Peptides; 2011 Jun; 32(6):1313-9. PubMed ID: 21453734
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4 regulates pancreatic ABCA1 transcription via CaMKK/CaMKIV pathway.
Li J; Murao K; Imachi H; Masugata H; Iwama H; Tada S; Zhang GX; Kobayashi R; Ishida T; Tokumitsu H
J Cell Mol Med; 2010 May; 14(5):1083-7. PubMed ID: 19874424
[TBL] [Abstract][Full Text] [Related]
17. The expression of ATP-binding cassette transporters in hypertensive patients.
Xu M; Zhou H; Gu Q; Li C
Hypertens Res; 2009 Jun; 32(6):455-61. PubMed ID: 19390536
[TBL] [Abstract][Full Text] [Related]
18. Effects of niacin and chromium on the expression of ATP-binding cassette transporter A1 and apolipoprotein A-1 genes in HepG2 cells.
Siripurkpong P; Na-Bangchang K
J Nutr Biochem; 2009 Apr; 20(4):261-8. PubMed ID: 18602814
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway.
Gupta NA; Mells J; Dunham RM; Grakoui A; Handy J; Saxena NK; Anania FA
Hepatology; 2010 May; 51(5):1584-92. PubMed ID: 20225248
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
Ojima A; Ishibashi Y; Matsui T; Maeda S; Nishino Y; Takeuchi M; Fukami K; Yamagishi S
Am J Pathol; 2013 Jan; 182(1):132-41. PubMed ID: 23159951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
